Taira Yamamoto

Dr. Taira Yamamoto


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
KKKan Kajimoto
Kan Kajimoto
TYTaira Yamamoto
Taira Yamamoto
AAAtsushi Amano
Atsushi Amano

1 July 2015 in The American Journal of Cardiology
Verified
Journal Article
Open access
YSYuichiro Sato
Yuichiro Sato
TKTomoko S. Kato
Tomoko S. Kato
AOAtsumi Oishi
Atsumi Oishi
TYTaira Yamamoto
Taira Yamamoto
KKKenji Kuwaki
Kenji Kuwaki
AAAtsushi Amano
Atsushi Amano
Renal dysfunction is a major adverse event after cardiovascular surgery. Therefore, the preoperative prediction of which patients will require renal replacement therapy (RRT) after cardiac surgery is an important issue. In the present study, 1,822 consecutive patients who underwent cardiovascular surgery from 2008 and 2013 at a single institution were reviewed. Patients who were already receiving long-term hemodialysis before surgery (n = 134) were excluded. The remaining 1,688 patients were separated into 2 groups: those requiring postoperative RRT and those without RRT requirement. A total of 128 patients (7.6%) required RRT. Patients requiring RRT had greater perioperative blood loss, longer intubation time, and longer hospital stays (p <0.0001 for all). Multivariate analysis revealed that cardiopulmonary bypass use, preoperative body surface area, the left ventricular ejection fraction, serum albumin, and creatinine were independent risk factors for postoperative RRT (odds ratios 2.435, 0.204, 0.976, 0.556, and 5.394, 95% confidence intervals 1.471 to 4.140, 0.054 to 0.841, 0.962 to 1.025, 0.363 to 0.860, and 3.671 to 8.223, respectively, p <0.05 for all). A subgroup of patients with relatively preserved renal function before surgery (creatinine <1.12 mg/dl, a cut-off value for RRT requirement obtained from receiver-operating characteristic curve analysis [area under the curve 0.74748, sensitivity 60.2%, specificity 85.0%]) showed that preoperative serum albumin concentration was most significantly associated with postoperative RRT requirement (odds ratio 0.048, 95% confidence interval 0.023 to 0.095, p <0.0001). In conclusion, cardiopulmonary bypass use, preoperative renal impairment as reflected by elevated creatinine level, small body size, a low left ventricular ejection fraction, and hypoalbuminemia were associated with a requirement for postoperative RRT. In patients with preserved renal function, hypoalbuminemia was most significantly related to requirement for RRT.

26 February 2012 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
KKKan Kajimoto
Kan Kajimoto
KMKatsumi Miyauchi
Katsumi Miyauchi
TYTaira Yamamoto
Taira Yamamoto
HDHiroyuki Daida
Hiroyuki Daida
AAAtsushi Amano
Atsushi Amano
Background and aim: Coronary artery bypass surgery (CABG) is the standard treatment for left main coronary artery (LMCA) disease. However, percutaneous coronary intervention using drug‐eluting stents (DES‐PCI) is now widely used and is associated with improved outcomes following coronary revascularization. The goal of this study was to assess early outcomes associated with CABG and DES‐PCI among patients with LMCA disease through a meta‐analysis of randomized controlled trials. Methods and Results: After searching of electronic databases, three randomized controlled trials with 2601 patients were identified. All‐cause death occurred in 3.3% with CABG and 3.6% with DES‐PCI (odds ratio [OR], 0.92; 95% confidence interval [CI]= 0.60 to 1.40; p = 0.76). The incidence of myocardial infarction was 2.6% with CABG and 3.8% with DES‐PCI (OR, 0.67; 95% CI = 0.43 to 1.05; p = 0.10). Target vessel revascularization occurred in 5.1% with CABG and 11.7% with DES‐PCI (OR, 0.40; 95% CI = 0.29 to 0.55; p < 0.0001). Major adverse cardiac and cerebrovascular events (MACCE) occurred in 10.7% with CABG and 15.7% with DES‐PCI (OR, 0.40; 95% CI = 0.29 to 0.55; p < 0.0001). Conclusions: DES‐PCI is a safe alternative to CABG for the management of LMCA disease. However, CABG was superior to DES‐PCI in terms of MACCE and need for target vessel revascularization at one year. Thus, CABG remains the standard of care for the treatment of LMCA disease.

1 March 2012 in Journal of Cardiology
Verified
Journal Article
Closed access
SDShizuyuki Dohi
Shizuyuki Dohi
KKKan Kajimoto
Kan Kajimoto
KMKatsumi Miyauchi
Katsumi Miyauchi
TYTaira Yamamoto
Taira Yamamoto
KTKeiichi Tambara
Keiichi Tambara
AAAtsushi Amano
Atsushi Amano

13 September 2016 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
TKTomoko S. Kato
Tomoko S. Kato
HNHiroshi Nakamura
Hiroshi Nakamura
MMMai Murata
Mai Murata
KKKishio Kuroda
Kishio Kuroda
HSHitoshi Suzuki
Hitoshi Suzuki
AAAtsushi Amano
Atsushi Amano
Adequate fluid management is an important component of patient care following cardiac surgery. Our aim in this study was to determine the benefits of tolvaptan, an oral selective vasopressin-2 receptor antagonist that causes electrolyte-free water diuresis, in postoperative fluid management. We prospectively examined the effect of tolvaptan on renal excretion of electrolytes and urea nitrogen in cardiac surgery patients. Patients undergoing coronary artery bypass surgery were randomized to receive conventional loop diuretics (Group C, n = 30) or conventional loop diuretic therapy plus tolvaptan (Group T, n = 27). Fractional excretions of sodium (FENA), potassium (FEK) and urea nitrogen (FEUN) were measured in both groups during post-surgical hospitalization. Urine output was greater with tolvaptan (Group T) than without it (Group C), and some patients in Group C required intravenous as well as oral loop diuretics. Serum sodium concentrations decreased after surgery in Group C, but were unchanged in Group T (postoperative day [POD] 3, 139.8 ± 3.5 vs. 142.3 ± 2.6 mEq/L, p = 0.006). However, postoperative FENA values in Group C did not decrease, and the values were similar in both groups. Serum potassium levels remained lower and FEK values remained higher than the preoperative values, but only in Group C (all p < 0.05). BUN increased postoperatively in both groups, but it remained higher than its preoperative value only in Group C (all p < 0.01). Group T showed an initial increase in BUN, which peaked and then returned to its preoperative value within a week. The FEUN increased postoperatively in both groups, but the change was more pronounced in Group T (POD7, 52.7 ± 9.3 vs. 58.2 ± 6.5 %, p = 0.025). Renal excretion of sodium and potassium reflects the changes in serum concentration in patients treated with tolvaptan. Patients treated only with loop diuretics showed a continuous excretion of sodium and potassium that led to electrolyte imbalance, whereas the combination of loop diuretics and tolvaptan increased renal urea nitrogen elimination. Tolvaptan therefore appears to be an effective diuretic that minimally affects serum electrolytes while adequately promoting the elimination of urea nitrogen from the kidneys in patients undergoing coronary artery bypass surgery. The present study is registered with the UMIN Clinical Trials Registry (ID: UMIN000011039 )

14 February 2012 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
KKKenji Kuwaki
Kenji Kuwaki
AAAtsushi Amano
Atsushi Amano
HIHirotaka Inaba
Hirotaka Inaba
TYTaira Yamamoto
Taira Yamamoto
TMTakeshi Matsumura
Takeshi Matsumura
SMSatoshi Matsushita
Satoshi Matsushita
Background: The purpose of this study was to evaluate clinical risk factors and assess the impact of the Society of Thoracic Surgeons (STS) scores on outcomes after contemporary aortic valve replacement (AVR) for aortic stenosis (AS). Methods: We retrospectively analyzed the data from 209 consecutive patients with AS (mean 69 ± 9 years) who underwent AVR. The outcomes measured included operative mortality, postoperative complications, postoperative prolonged length of stay (PLOS), discharge to nonhome location, and mid‐term mortality. Results: Operative mortality was 3.8%, and five‐year survival was 88.6 ± 2.8%. Multivariable analysis revealed preoperative New York Heart Association (NYHA) class as a significant predictor of both operative mortality (p = 0.03; odds ratio [OR]: 8.5) and mid‐term mortality (p = 0.02; OR: 10.5). NYHA class also emerged as an independent predictor for postoperative complications (p = 0.002; OR: 5.8) and PLOS (p = 0.01; OR: 2.5). Other preoperative independent predictors included dialysis for PLOS (p = 0.04; OR: 2.9), age (p = 0.03; OR: 1.1), and left ventricular ejection fraction (EF; p = 0.03; OR: 0.9) for nonhome discharge, and EF for mid‐term mortality (p = 0.01; OR: 0.9). The mean STS‐PROM (predicted risk of mortality) was 4.6% ± 6.1%, and thus, the observed‐to‐expected (O/E) ratio of operative mortality in our series was 0.82. Conclusions: Advanced NYHA class, older age, dialysis, and lower EF are significant independent preoperative risk factors for early and mid‐term results of AVR for AS. Consideration of these predictors should be used to identify high‐risk patients requiring AVR for AS.